We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Cancer treatment drugs.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Cancer treatment drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Cancer treatment drugs Product List

1～7 item / All 7 items

Displayed results
[Research Material] Global Market for Peptide Cancer Therapeutics

[Research Material] Global Market for Peptide Cancer Therapeutics

Global Market for Peptide Cancer Therapeutics: Goserelin, Bortezomib, Leuprolide, Others, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Peptide Based Cancer Therapeutics Market) investigates and analyzes the current status and outlook for the global market of peptide cancer therapeutics over the next five years. It includes information on the overview of the global peptide cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the peptide cancer therapeutics market include Goserelin, Bortezomib, Leuprolide, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of peptide cancer therapeutics. It also includes the market share of major companies in peptide cancer therapeutics, product and business overviews, and sales performance.

  • Other services
  • Cancer treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

[Research Material] Global Market for Treatments of Nasopharyngeal Cancer

World Market for Oropharyngeal Cancer Treatments: BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others...

This research report (Global Nasopharyngeal Cancer Drug Market) investigates and analyzes the current status and outlook for the global market of nasopharyngeal cancer treatments over the next five years. It includes information on the overview of the global nasopharyngeal cancer drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include BGBA317, CBT501, Apatinib, APG1387, ARGX110, ATA129, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for nasopharyngeal cancer treatments. It also includes the market share of major companies in the nasopharyngeal cancer drug market, product and business overviews, and sales performance.

  • Other services
  • Cancer treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Renal Cell Carcinoma Therapeutics

[Research Material] Global Market for Renal Cell Carcinoma Therapeutics

World Market for Renal Cell Carcinoma Treatments: Sutent (Sunitinib), Nexavar (Sorafenib), Votrient (Pazopanib), A ...

This research report (Global Renal Cell Carcinoma Drugs Market) investigates and analyzes the current status and outlook for the global market of renal cell carcinoma treatment drugs over the next five years. It includes information on the overview of the global renal cell carcinoma treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Sutent (sunitinib), Nexavar (sorafenib), Votrient (pazopanib), Avastin (bevacizumab), Afinitor (everolimus), Inlyta (axitinib), Torisel (temsirolimus), and Proleukin (aldesleukin). The segments by application focus on mucinous tubular and spindle cell carcinoma (MTSCC), multicystic clear cell renal cell carcinoma, tubulocystic renal cell carcinoma, thyroid-like follicular renal cell carcinoma, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services
  • Cancer treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Endocrine Cancer Treatment Drugs

[Research Material] Global Market for Endocrine Cancer Treatment Drugs

World Market for Endocrine Cancer Treatment Drugs: Somatostatin Analogues, Targeted Therapy Drugs, Chemotherapy Drugs, Hospitals, Clinics, Oncology Centers, Outpatient Surgery Centers

This research report (Global Neuroendocrine Carcinoma Drugs Market) investigates and analyzes the current status and outlook for the global market of endocrine cancer treatment drugs over the next five years. It includes information on the overview of the global endocrine cancer treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include somatostatin analogs, targeted therapy drugs, and chemotherapy drugs, while the segments by application focus on hospitals, clinics, oncology centers, and outpatient surgery centers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, calculating the market size for endocrine cancer treatment drugs. It also includes the market share of major companies in the endocrine cancer treatment drug sector, product and business overviews, and sales performance.

  • Other services
  • Cancer treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

[Research Material] Global Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs

World Market for Kidney Cancer & Renal Cell Carcinoma (RCC) Treatment Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Cabomety...

This research report (Global Kidney Cancer and Renal Cell Carcinoma (RCC)) investigates and analyzes the current status and outlook for the global market of kidney cancer and renal cell carcinoma (RCC) treatment drugs over the next five years. It includes information on the overview of the global kidney cancer and renal cell carcinoma (RCC) treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Afinitor (everolimus), Avastin (bevacizumab), Cabometyx (cabozantinib), Inlyta (axitinib), Nexavar (sorafenib), Proleukin (aldesleukin), Torisel (temsirolimus), Sutent (sunitinib), and Votrient (pazopanib). The segments by application target hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa.

  • Other services
  • Cancer treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Merkel Cell Carcinoma Treatment

[Research Material] Global Market for Merkel Cell Carcinoma Treatment

World Market for Merkel Cell Carcinoma Treatment: Chemotherapy, Immunotherapy, Combination Therapy, Others, Hospitals, Outpatient Surgery Centers, Others

This research report (Global Merkel Cell Carcinoma Treatment Market) investigates and analyzes the current state and future outlook of the global market for Merkel cell carcinoma treatment over the next five years. It includes information on the overview of the global Merkel cell carcinoma treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the Merkel cell carcinoma treatment market include chemotherapy, immunotherapy, combination therapy, and others, while the segments by application include hospitals, outpatient surgical centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for Merkel cell carcinoma treatment. It also includes the market share of major companies in the Merkel cell carcinoma treatment sector, product and business overviews, and sales performance.

  • Other services
  • Cancer treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Laryngeal Cancer Treatment Drugs

[Research Material] Global Market for Laryngeal Cancer Treatment Drugs

Global Market for Laryngeal Cancer Treatment Drugs: Biologics, Small Molecules, Hospitals, Clinics, Others

This research report (Global Laryngeal Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for laryngeal cancer therapeutics over the next five years. It includes information on the overview of the global laryngeal cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on biologics and small molecules, while the segments by application target hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for laryngeal cancer therapeutics. It also includes the market share of major companies in laryngeal cancer therapeutics, product and business overviews, and sales performance.

  • Other services
  • Cancer treatment drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Cancer treatment drugs

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.